3 ms·
That's a nice explanation. If I were him I'd ask why not just print the spikes at the vaccine factory and inject them? TBH I'm not sure if it's easier/cheaper
by innomatics 4y ago
That's a nice explanation.
If I were him I'd ask why not just print the spikes at the vaccine factory and inject them?
TBH I'm not sure if it's easier/cheaper to use the 3D-printers in our cells, or its more about accurate delivery to the right places, or something else.
- civilized 4y agoSome educated guesses: 1. We don't have "ribosomes at scale" 2. We don't have a way to separate the ribosome product from the factory 3. Keeping the product stable is hard
- mrguyorama 4y agoAnother interesting reason is that if you do it the mRNA way, you will continue to internally produce those spike proteins to train your immune system for a week or two
- ch4s3 4y agoBasically it takes longer to produce them at scale, and they've been less effective at preventing covid infection in clinical trials.
- arrosenberg 4y agoThe non-mRNA vaccines do work like that. They use big vats of bacteria as bioreactors and ship the finished product. Long term, mRNA is a more flexible solution - just ship the blueprints and let people make it themselves.